Published: May 11, 2021
BILLERICA, Mass. (BUSINESS WIRE) Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, effective June 9, 2021.
“We are excited to welcome Masoud to our team at such an important moment for Quanterix,” said Kevin Hrusovsky, Chairman and Chief Executive Officer Quanterix. “We are making important strides in advancing our diagnostic capability and assays, given the NIH RADx funding, our COVID-19 Emergency Use Authorizations and advances in our neurology suite of assays for Multiple Sclerosis, Alzheimer’s and Parkinson’s research as well as phase III drug trials. Masoud’s strong growth track record of doubling PerkinElmer’s diagnostics franchise, wealth of experience, deep roots in the life sciences and business acumen will be instrumental a
Hospitalized pregnant women less likely to die from COVID-19 than non-pregnant patients
Pregnant women who are hospitalized with COVID-19 and viral pneumonia are less likely than non-pregnant women to die from these infections, according to a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth) and the University of Maryland School of Medicine (UMSOM).
The study was published today in
Annals of Internal Medicine.
The study examined medical records from nearly 1,100 pregnant patients and more than 9,800 non-pregnant women ages 15 to 45 who were hospitalized with COVID-19 and pneumonia. Less than 1% of the pregnant patients died from COVID-19 compared to 3.5% of non-pregnant patients, according to the study findings.
Customers formed a long line for groceries outside of Fiesta on Stassney Lane in Southeast Austin in February. A bill that the House advanced limits the governor s emergency powers during a pandemic. An amendment that would have banned statewide or local mask mandates narrowly failed. Credit: Miguel Gutierrez Jr./The Texas Tribune
Sign up for The Brief, our daily newsletter that keeps readers up to speed on the most essential Texas news.
The Texas House has approved a sweeping bill that would reform the governorâs emergency powers during a pandemic and involve the Legislature during such instances.
House members voted 92-45 for House Bill 3 in a preliminary vote Monday. They gave formal approval Tuesday, sending the bill to the Senate for consideration.
E-Mail
Pregnant women who develop severe COVID-19 infections that require hospitalization for pneumonia and other complications may not be more likely to die from these infections than non-pregnant women. In fact, they may have significantly lower death rates than their non-pregnant counterparts. That is the finding of a new study published today in the
Annals of Internal Medicine conducted by researchers at the University of Maryland School of Medicine (UMSOM).
The study examined medical records from nearly 1,100 pregnant women and more than 9,800 non-pregnant patients aged 15 to 45 who were hospitalized with COVID-19 and pneumonia. Slightly less than 1 percent of the pregnant patients died from COVID-19 compared to 3.5 percent of non-pregnant patients, according to the study findings.
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
- Vadadustat New Drug Application (NDA) submitted to the U.S. Food and Drug Administration (FDA)
- Results of global Phase 3 programs for vadadustat published in New England Journal of Medicine
- Conference call today at 9:00 a.m. ET
News provided by
Share this article
®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the first quarter ended March 31, 2021 and highlighted recent corporate milestones. The Company will host a conference call today, Monday, May 10, 2021, at 9:00 a.m. Eastern Time.